# PERMEON BIOLOGICS, INC. — Form D

PERMEON BIOLOGICS, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-29. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-12-29
- Form: D
- Accession: 0001507236-11-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 2
- Date of first sale: 2011-12-19
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-170937

## Issuer

- Name: PERMEON BIOLOGICS, INC.
- CIK: 0001507236
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-945-7780

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Noubar G Afeyan, Ph.D. | Director | Cambridge, MA |
| Douglas G Cole, M.D. | Director | Cambridge, MA |
| Keith L Crandell | Director | WOBURN, MA |
| John Edwards | Director | Atlanta, GA |
| John Edwards | Executive Officer | Atlanta, GA |
| Douglas Cole, M.D. | Director | Cambridge, MA |
| Noubar L Afeyan, Ph.D. | Director | Cambridge, MA |
| Alex Franzusoff | Executive Officer | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-12-08](https://search.stillhousedata.com/formd/0001507236-10-000001) | D | $3.5M | $3.5M |

## More

- [CIK 1507236 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1507236&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001507236-11-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.